| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microfluidic Analytical Techniques | 3 | 2016 | 42 | 1.240 |
Why?
|
| Proteomics | 3 | 2018 | 1431 | 0.950 |
Why?
|
| Antibodies | 3 | 2021 | 845 | 0.720 |
Why?
|
| Antibody Affinity | 1 | 2020 | 62 | 0.710 |
Why?
|
| Biosensing Techniques | 1 | 2018 | 79 | 0.600 |
Why?
|
| B7-H1 Antigen | 3 | 2019 | 1061 | 0.570 |
Why?
|
| ErbB Receptors | 8 | 2019 | 2337 | 0.490 |
Why?
|
| Protein Interaction Maps | 1 | 2014 | 150 | 0.430 |
Why?
|
| Multiprotein Complexes | 2 | 2017 | 386 | 0.420 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2014 | 201 | 0.410 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2016 | 2081 | 0.350 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 167 | 0.340 |
Why?
|
| Signal Transduction | 13 | 2021 | 12145 | 0.330 |
Why?
|
| I-kappa B Kinase | 4 | 2011 | 251 | 0.310 |
Why?
|
| Fluorescent Dyes | 1 | 2010 | 465 | 0.310 |
Why?
|
| Programmed Cell Death 1 Receptor | 3 | 2021 | 1071 | 0.300 |
Why?
|
| STAT3 Transcription Factor | 2 | 2014 | 1142 | 0.300 |
Why?
|
| src-Family Kinases | 1 | 2010 | 480 | 0.300 |
Why?
|
| Proteins | 1 | 2016 | 1976 | 0.300 |
Why?
|
| Transcription, Genetic | 2 | 2017 | 3148 | 0.280 |
Why?
|
| Genes, ras | 2 | 2005 | 670 | 0.250 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2005 | 108 | 0.250 |
Why?
|
| HeLa Cells | 4 | 2018 | 1651 | 0.250 |
Why?
|
| Genes, Dominant | 1 | 2005 | 331 | 0.240 |
Why?
|
| NF-kappa B | 4 | 2009 | 1585 | 0.230 |
Why?
|
| Cell Line, Tumor | 15 | 2019 | 14928 | 0.220 |
Why?
|
| Colonic Neoplasms | 3 | 2021 | 1424 | 0.210 |
Why?
|
| Thrombectomy | 1 | 2024 | 174 | 0.210 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2024 | 165 | 0.210 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 2010 | 506 | 0.200 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2021 | 19 | 0.190 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2016 | 949 | 0.180 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 1 | 2021 | 58 | 0.180 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 2093 | 0.180 |
Why?
|
| Epidermal Growth Factor | 2 | 2014 | 427 | 0.180 |
Why?
|
| Galectins | 1 | 2021 | 73 | 0.180 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2010 | 1872 | 0.180 |
Why?
|
| Phosphorylation | 6 | 2016 | 4887 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2021 | 9065 | 0.170 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2019 | 21 | 0.170 |
Why?
|
| Mice | 19 | 2022 | 35455 | 0.160 |
Why?
|
| Animals | 25 | 2022 | 61175 | 0.160 |
Why?
|
| Limit of Detection | 1 | 2018 | 83 | 0.160 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 3362 | 0.150 |
Why?
|
| Breast Neoplasms | 8 | 2019 | 16073 | 0.150 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2018 | 55 | 0.150 |
Why?
|
| Fusariosis | 1 | 2017 | 11 | 0.150 |
Why?
|
| Guanylate Cyclase | 1 | 2017 | 76 | 0.150 |
Why?
|
| Specimen Handling | 1 | 2019 | 302 | 0.150 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2017 | 98 | 0.140 |
Why?
|
| Brain Abscess | 1 | 2017 | 68 | 0.140 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2017 | 112 | 0.140 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2018 | 389 | 0.140 |
Why?
|
| Protein Transport | 2 | 2016 | 741 | 0.140 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2016 | 111 | 0.140 |
Why?
|
| Protein-Arginine N-Methyltransferases | 2 | 2015 | 219 | 0.130 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2017 | 168 | 0.130 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 1663 | 0.130 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2018 | 1011 | 0.130 |
Why?
|
| Adenocarcinoma | 4 | 2021 | 7877 | 0.130 |
Why?
|
| Microscopy | 1 | 2016 | 192 | 0.130 |
Why?
|
| Diabetes Complications | 1 | 2017 | 317 | 0.130 |
Why?
|
| Twist-Related Protein 1 | 1 | 2016 | 132 | 0.130 |
Why?
|
| Humans | 34 | 2024 | 270969 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2019 | 802 | 0.130 |
Why?
|
| Calibration | 1 | 2016 | 340 | 0.120 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2017 | 382 | 0.120 |
Why?
|
| Fluorescence | 2 | 2014 | 200 | 0.120 |
Why?
|
| Protein Binding | 4 | 2021 | 3495 | 0.120 |
Why?
|
| Quality Control | 1 | 2016 | 459 | 0.120 |
Why?
|
| Apoptosis | 3 | 2010 | 7756 | 0.120 |
Why?
|
| Cells | 1 | 2014 | 33 | 0.120 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2019 | 992 | 0.120 |
Why?
|
| Optical Imaging | 1 | 2015 | 162 | 0.120 |
Why?
|
| Cetuximab | 1 | 2015 | 473 | 0.110 |
Why?
|
| Cell Engineering | 1 | 2014 | 37 | 0.110 |
Why?
|
| Molecular Conformation | 1 | 2014 | 171 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2011 | 2392 | 0.110 |
Why?
|
| Methylation | 4 | 2017 | 598 | 0.110 |
Why?
|
| Protein Kinases | 2 | 2008 | 888 | 0.110 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2013 | 353 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 5 | 2021 | 2406 | 0.110 |
Why?
|
| Estrogen Receptor alpha | 1 | 2017 | 718 | 0.110 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 276 | 0.100 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2017 | 508 | 0.100 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2011 | 37 | 0.100 |
Why?
|
| Tissue Array Analysis | 1 | 2014 | 761 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 3660 | 0.100 |
Why?
|
| Quantum Dots | 1 | 2010 | 31 | 0.090 |
Why?
|
| Spike Glycoprotein, Coronavirus | 2 | 2023 | 250 | 0.090 |
Why?
|
| Receptor, Notch1 | 1 | 2011 | 221 | 0.090 |
Why?
|
| Carcinogenesis | 1 | 2016 | 1040 | 0.090 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 1003 | 0.090 |
Why?
|
| Jurkat Cells | 2 | 2021 | 314 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 2 | 2018 | 5231 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 314 | 0.080 |
Why?
|
| Tyrosine | 1 | 2011 | 508 | 0.080 |
Why?
|
| Acetyltransferases | 1 | 2010 | 146 | 0.080 |
Why?
|
| Electric Stimulation Therapy | 2 | 2001 | 128 | 0.080 |
Why?
|
| Transfection | 5 | 2017 | 2987 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 530 | 0.080 |
Why?
|
| Equipment Failure Analysis | 1 | 2010 | 334 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 473 | 0.080 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2009 | 512 | 0.080 |
Why?
|
| Epithelium | 1 | 2010 | 726 | 0.080 |
Why?
|
| 3T3 Cells | 2 | 2005 | 367 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 7711 | 0.080 |
Why?
|
| Cell Line, Transformed | 2 | 2005 | 397 | 0.080 |
Why?
|
| Genes, myc | 1 | 2009 | 360 | 0.080 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2008 | 129 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2015 | 1693 | 0.070 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2018 | 1307 | 0.070 |
Why?
|
| Arginine | 1 | 2011 | 515 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2016 | 5677 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 723 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2010 | 515 | 0.070 |
Why?
|
| MCF-7 Cells | 2 | 2019 | 552 | 0.070 |
Why?
|
| Mammary Glands, Animal | 1 | 2010 | 546 | 0.070 |
Why?
|
| Breast | 1 | 2013 | 1361 | 0.070 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 1804 | 0.070 |
Why?
|
| Equipment Design | 1 | 2010 | 1229 | 0.070 |
Why?
|
| Immunoglobulin G | 1 | 2010 | 1065 | 0.070 |
Why?
|
| Transgenes | 2 | 2005 | 573 | 0.070 |
Why?
|
| Quinazolines | 1 | 2011 | 934 | 0.070 |
Why?
|
| Isopropyl Thiogalactoside | 1 | 2005 | 5 | 0.070 |
Why?
|
| Cytosine Deaminase | 1 | 2006 | 42 | 0.070 |
Why?
|
| Liver Neoplasms, Experimental | 2 | 2011 | 189 | 0.070 |
Why?
|
| Endostatins | 1 | 2006 | 48 | 0.070 |
Why?
|
| Bile Acids and Salts | 1 | 2008 | 255 | 0.070 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 200 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 6181 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2005 | 697 | 0.060 |
Why?
|
| S Phase | 1 | 2005 | 285 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2007 | 431 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 4458 | 0.060 |
Why?
|
| Cricetinae | 2 | 2022 | 712 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 590 | 0.060 |
Why?
|
| Neoplasm Proteins | 2 | 2017 | 3276 | 0.060 |
Why?
|
| Nucleocapsid | 1 | 2023 | 13 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2011 | 1581 | 0.060 |
Why?
|
| Carrier Proteins | 2 | 2009 | 2032 | 0.060 |
Why?
|
| RNA, Small Interfering | 4 | 2011 | 2216 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 1283 | 0.060 |
Why?
|
| Neoplasm Transplantation | 2 | 2018 | 1533 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2022 | 4239 | 0.060 |
Why?
|
| Binding Sites | 2 | 2018 | 2209 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 2 | 2007 | 1583 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 5228 | 0.050 |
Why?
|
| Insulin Resistance | 1 | 2008 | 742 | 0.050 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2017 | 281 | 0.050 |
Why?
|
| Mesocricetus | 1 | 2022 | 116 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2024 | 197 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2023 | 224 | 0.050 |
Why?
|
| Barrett Esophagus | 1 | 2008 | 572 | 0.050 |
Why?
|
| Administration, Intranasal | 1 | 2022 | 202 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2022 | 389 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2017 | 1770 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 5121 | 0.050 |
Why?
|
| Fibrinolytic Agents | 1 | 2024 | 340 | 0.050 |
Why?
|
| Cell Line | 5 | 2009 | 5122 | 0.050 |
Why?
|
| Fullerenes | 1 | 2000 | 10 | 0.050 |
Why?
|
| Cattle | 2 | 2018 | 800 | 0.050 |
Why?
|
| Antineoplastic Agents, Immunological | 2 | 2021 | 1331 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2009 | 4061 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2003 | 632 | 0.040 |
Why?
|
| Photosensitizing Agents | 1 | 2000 | 79 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 1597 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2017 | 1509 | 0.040 |
Why?
|
| Brain | 1 | 2013 | 4219 | 0.040 |
Why?
|
| Carbon | 1 | 2000 | 161 | 0.040 |
Why?
|
| THP-1 Cells | 1 | 2019 | 55 | 0.040 |
Why?
|
| Sodium Chloride | 1 | 2000 | 157 | 0.040 |
Why?
|
| Female | 12 | 2024 | 147624 | 0.040 |
Why?
|
| Dengue Virus | 1 | 2000 | 130 | 0.040 |
Why?
|
| A549 Cells | 1 | 2019 | 131 | 0.040 |
Why?
|
| Glycosylation | 1 | 2019 | 220 | 0.040 |
Why?
|
| False Negative Reactions | 1 | 2019 | 281 | 0.040 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2011 | 2160 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2019 | 340 | 0.040 |
Why?
|
| Melanoma, Experimental | 1 | 2021 | 377 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 1999 | 304 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2006 | 1631 | 0.040 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2018 | 47 | 0.040 |
Why?
|
| Endovascular Procedures | 1 | 2024 | 537 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2011 | 5298 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 1168 | 0.040 |
Why?
|
| Cell Movement | 2 | 2016 | 2510 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2008 | 1559 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 1078 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2003 | 1379 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 717 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 5019 | 0.030 |
Why?
|
| Acetylation | 1 | 2017 | 521 | 0.030 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 1 | 2016 | 40 | 0.030 |
Why?
|
| Actins | 1 | 2019 | 615 | 0.030 |
Why?
|
| Cryoelectron Microscopy | 1 | 2017 | 250 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2021 | 1024 | 0.030 |
Why?
|
| Registries | 1 | 2024 | 2300 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2005 | 6221 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 557 | 0.030 |
Why?
|
| Neoplasms | 3 | 2019 | 15797 | 0.030 |
Why?
|
| Stilbenes | 1 | 2016 | 91 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2015 | 79 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2017 | 966 | 0.030 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2016 | 150 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2011 | 4793 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2016 | 654 | 0.030 |
Why?
|
| Printing | 1 | 2014 | 7 | 0.030 |
Why?
|
| Micromanipulation | 1 | 2014 | 10 | 0.030 |
Why?
|
| Esophageal Neoplasms | 1 | 2008 | 3258 | 0.030 |
Why?
|
| Proteolysis | 1 | 2016 | 374 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 3098 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2017 | 3962 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 1093 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 751 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2016 | 860 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2013 | 154 | 0.030 |
Why?
|
| Patient Selection | 1 | 2019 | 2111 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2017 | 859 | 0.020 |
Why?
|
| Lung | 1 | 2022 | 3234 | 0.020 |
Why?
|
| Protein Methyltransferases | 1 | 2011 | 44 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2014 | 597 | 0.020 |
Why?
|
| Cell Communication | 1 | 2014 | 508 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 5015 | 0.020 |
Why?
|
| N-Terminal Acetyltransferase A | 1 | 2010 | 14 | 0.020 |
Why?
|
| N-Terminal Acetyltransferase E | 1 | 2010 | 14 | 0.020 |
Why?
|
| Histones | 1 | 2017 | 1493 | 0.020 |
Why?
|
| Cullin Proteins | 1 | 2009 | 39 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2008 | 1710 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2011 | 568 | 0.020 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2009 | 107 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2021 | 9311 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2009 | 185 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2008 | 105 | 0.020 |
Why?
|
| Chenodeoxycholic Acid | 1 | 2008 | 23 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2008 | 137 | 0.020 |
Why?
|
| Inflammation | 2 | 2008 | 2560 | 0.020 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2008 | 53 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2008 | 90 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2015 | 4341 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2011 | 7333 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 11638 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 3064 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2009 | 357 | 0.020 |
Why?
|
| Sulfones | 1 | 2008 | 147 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 1800 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2009 | 528 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2021 | 3518 | 0.020 |
Why?
|
| Gene Expression | 2 | 2009 | 3574 | 0.020 |
Why?
|
| Time Factors | 2 | 2017 | 13261 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2009 | 578 | 0.020 |
Why?
|
| Heterozygote | 1 | 2010 | 1013 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 5161 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 3002 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 4064 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 263 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2006 | 341 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 3980 | 0.020 |
Why?
|
| Gastroesophageal Reflux | 1 | 2008 | 351 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 4893 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 1475 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 4744 | 0.010 |
Why?
|
| Cell Division | 1 | 2008 | 2555 | 0.010 |
Why?
|
| Alleles | 1 | 2010 | 2398 | 0.010 |
Why?
|
| Autophagy | 1 | 2010 | 929 | 0.010 |
Why?
|
| Colostrum | 1 | 2003 | 49 | 0.010 |
Why?
|
| Sirolimus | 1 | 2008 | 832 | 0.010 |
Why?
|
| Lovastatin | 1 | 2003 | 59 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2010 | 1846 | 0.010 |
Why?
|
| Antibodies, Blocking | 1 | 2003 | 91 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2017 | 5360 | 0.010 |
Why?
|
| Nitriles | 1 | 2008 | 940 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 1866 | 0.010 |
Why?
|
| Models, Biological | 1 | 2011 | 3242 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2009 | 1540 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2024 | 34335 | 0.010 |
Why?
|
| Hydrochloric Acid | 1 | 2001 | 19 | 0.010 |
Why?
|
| Sodium Hydroxide | 1 | 2001 | 17 | 0.010 |
Why?
|
| Encephalitis Viruses | 1 | 2000 | 6 | 0.010 |
Why?
|
| Acetic Acid | 1 | 2001 | 33 | 0.010 |
Why?
|
| Singlet Oxygen | 1 | 2000 | 8 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2011 | 2883 | 0.010 |
Why?
|
| Viral Plaque Assay | 1 | 2000 | 48 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 1575 | 0.010 |
Why?
|
| Isomerism | 1 | 2000 | 62 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2003 | 1019 | 0.010 |
Why?
|
| Egg White | 1 | 2000 | 8 | 0.010 |
Why?
|
| Transaminases | 1 | 2000 | 81 | 0.010 |
Why?
|
| Liver | 2 | 2001 | 2993 | 0.010 |
Why?
|
| Enterovirus | 1 | 2000 | 62 | 0.010 |
Why?
|
| Injections | 1 | 2001 | 288 | 0.010 |
Why?
|
| Electrodes | 1 | 2000 | 117 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6269 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2006 | 1078 | 0.010 |
Why?
|
| Light | 1 | 2000 | 270 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2001 | 577 | 0.010 |
Why?
|
| Phosphatidylserines | 1 | 1999 | 70 | 0.010 |
Why?
|
| Cell Size | 1 | 1999 | 147 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2000 | 598 | 0.010 |
Why?
|
| Ethanol | 1 | 2001 | 275 | 0.010 |
Why?
|
| Caspase 3 | 1 | 1999 | 479 | 0.010 |
Why?
|
| Luciferases | 1 | 1999 | 454 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 3621 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2000 | 1631 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 1999 | 702 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1999 | 810 | 0.010 |
Why?
|
| Caspases | 1 | 1999 | 685 | 0.010 |
Why?
|
| Oxygen | 1 | 2000 | 782 | 0.010 |
Why?
|
| Swine | 1 | 2000 | 1610 | 0.010 |
Why?
|
| Mutation | 2 | 2009 | 15640 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 5021 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1999 | 3069 | 0.010 |
Why?
|
| Rats | 1 | 2001 | 6233 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 73018 | 0.010 |
Why?
|
| Pregnancy | 1 | 2003 | 7898 | 0.010 |
Why?
|
| Male | 1 | 2008 | 127769 | 0.000 |
Why?
|